Peramivir (RAPIVAB (peramivir injection)

Awarded Limited / Sole Source Justification Posted

Solicitation number
75A50324F80012-LSJ
Agency
Set-aside
No set-aside

Opportunity facts

Contract number
36F79721D0166-75A50324F80012 Federal contract award
Place of performance
Durham, North Carolina 27703, United States

Notice details come from SAM.gov. Updated .

About this opportunity

This Limited / Sole Source Justification Notice is for the procurement of Peramivir (RAPIVAB (peramivir injection) 200mg/20ml vials (10mg/ml inj soln)) by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) under Solicitation Number 75A50324F80012-LSJ. The justification for the limited/sole source procurement is not provided. The contract was awarded to an unknown vendor on 2024-09-25 under Contract Number 36F79721D0166, but the contract value is unknown. The notice does not include any additional details on the quantity of goods, timeline for services, or other salient information.

Notice text

Peramivir (RAPIVAB (peramivir injection) 200mg/20ml vials (10mg/ml inj soln)); NDC 72769-0181-03.

Awarded contract 36F79721D0166 to unknown vendor for unknown amount on 2024-09-25.

Files

File Type Posted
Peramivir_LSJ_75A50324F80012.pdf PDF

Notice history

Notice Type Posted
This notice Latest Limited / Sole Source Justification
Peramivir (RAPIVAB (peramivir injection) Award Award Notice

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity